BC is a highly heterogeneous tumor based on gene expression profiles, and can be divided into three subtypes: luminal (ER-and/or PR-positive), HER2 enriched (HER2 positive), and basal subtypes (ER, PR, and HER2 negative) (Yeo and Guan, 2017). This evidence concerns the gene ERBB2 and neoplasm.